SGLT2 inhibitor requires co-administration with diuretics to effectively reduce interstitial fluid retention: the DAPA-BODY trialTakahiro Masuda, Yoshiyuki Morishita, Marina Miura et al.|Hypertension Research|2025Cited by 5
Clinicopathological Study on Endothelial Injury in Severe Glomerular Microangiopathy Induced by RamucirumabMasato Sakai, Haruyoshi Yoshida, M. Watanabe et al.|Internal Medicine|2025Cited by 1
Urinary β2-microglobulin as a Potential Biomarker for Early Treatment Selection: A Patient with Severe IgG4-related Tubulointerstitial NephritisDaisuke Nagata, Tetsu Akimoto, Masato Sakai et al.|Internal Medicine|2025Cited by 0